The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation.
Mutations in the photopigment rhodopsin are the major cause of autosomal dominant retinitis pigmentosa. The majority of mutations in rhodopsin lead to misfolding of the protein. Through the detailed examination of P23H and K296E mutant opsin processing in COS-7 cells, we have shown that the mutant protein does not accumulate in the Golgi, as previously thought, instead it forms aggregates that have many of the characteristic features of an aggresome. The aggregates form close to the centrosome and lead to the dispersal of the Golgi apparatus. Furthermore, these aggregates are ubiquitinated, recruit cellular chaperones and disrupt the intermediate filament network. Mutant opsin expression can disrupt the processing of normal opsin, as co-transfection revealed that the wild-type protein is recruited to mutant opsin aggregates. The degradation of mutant opsin is dependent on the proteasome machinery. Unlike the situation with DeltaF508-CFTR, proteasome inhibition does not lead to a marked increase in aggresome formation but increases the retention of the protein within the ER, suggesting that the proteasome is required for the efficient retrotranslocation of the mutant protein. Inhibition of N-linked glycosylation with tunicamycin leads to the selective retention of the mutant protein within the ER and increases the steady state level of mutant opsin. Glycosylation, however, has no influence on the biogenesis and targeting of wild-type opsin in cultured cells. This demonstrates that N-linked glycosylation is required for ER-associated degradation of the mutant protein but is not essential for the quality control of opsin folding. The addition of 9-cis-retinal to the media increased the amount of P23H, but not K296E, that was soluble and reached the plasma membrane. These data show that rhodopsin autosomal dominant retinitis pigmentosa is similar to many other neurodegenerative diseases in which the formation of intracellular protein aggregates is central to disease pathogenesis, and they suggest a mechanism for disease dominance.
Saliba
Richard S
RS
Division of Pathology, Institute of Ophthalmology, University College London, UK.
Munro
Peter M G
PM
Luthert
Philip J
PJ
Cheetham
Michael E
ME
D000818:Animals; D019556:COS Cells; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D003546:Cysteine Endopeptidases / Q000235:genetics* / Q000378:metabolism / Q000648:ultrastructure; D004224:Diterpenes; D005057:Eukaryotic Cells / Q000166:cytology / Q000378:metabolism*; D006031:Glycosylation / Q000187:drug effects; D006056:Golgi Apparatus / Q000378:metabolism / Q000648:ultrastructure; D002479:Inclusion Bodies / Q000235:genetics* / Q000378:metabolism / Q000648:ultrastructure; D008854:Microscopy, Electron; D018832:Molecular Chaperones / Q000235:genetics / Q000378:metabolism; D009097:Multienzyme Complexes / Q000235:genetics* / Q000378:metabolism / Q000648:ultrastructure; D009154:Mutation / Q000235:genetics; D015388:Organelles / Q000235:genetics* / Q000378:metabolism / Q000648:ultrastructure; D046988:Proteasome Endopeptidase Complex; D017510:Protein Folding; D021381:Protein Transport / Q000235:genetics*; D012172:Retinaldehyde / Q000494:pharmacology; D012174:Retinitis Pigmentosa / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D012243:Rhodopsin / Q000235:genetics* / Q000378:metabolism*; D014415:Tunicamycin / Q000494:pharmacology; D025801:Ubiquitin / Q000378:metabolism
D004224:Diterpenes; D018832:Molecular Chaperones; D009097:Multienzyme Complexes; D025801:Ubiquitin; D014415:Tunicamycin; C031390:9-cis-retinal; D012243:Rhodopsin; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex; D012172:Retinaldehyde